N2-quinolyl or isoquinolyl substituted purine derivatives, the preparation and uses thereof

Details for Australian Patent Application No. 2006257583 (hide)

Owner Zhe Jiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory

Inventors Wu, Zhanggui

Agent T J Pietras

Pub. Number AU-A-2006257583

PCT Pub. Number WO2006/133611

Priority 200510026846.3 16.06.05 CN

Filing date 23 January 2006

Wipo publication date 21 December 2006

International Classifications

C07D 473/16 (2006.01) Heterocyclic compounds containing purine ring systems

A61K 31/52 (2006.01)

A61K 31/7076 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07H 19/16 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

C07H 19/20 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2006/133611 Priority application(s): WO2006/133611

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006257609-Cell-and tissue culture device

2006257558-Compounds, preparation process, and uses thereof used for interrupting reuptake of 5-hydroxytryptamine and norepinephrine or treating diseases such as depression et al.